Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
3.500
-0.090 (-2.51%)
Jun 12, 2026, 9:18 AM CET
Scandinavian ChemoTech AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.46 | 3.67 | 0.95 | 0.92 | 5.85 | 8.68 |
Cash & Short-Term Investments | 1.46 | 3.67 | 0.95 | 0.92 | 5.85 | 8.68 |
Cash Growth | 43.07% | 286.51% | 2.82% | -84.23% | -32.60% | 484.65% |
Accounts Receivable | 2.92 | 0.99 | 1.25 | 0.12 | 0.86 | 0.65 |
Other Receivables | - | 0.67 | 0.64 | 1.04 | 0.81 | 0.88 |
Receivables | 2.92 | 1.67 | 1.89 | 1.16 | 1.67 | 1.53 |
Inventory | 3.1 | 2.79 | 3.31 | 4.03 | 3.1 | 2.25 |
Prepaid Expenses | - | 1.01 | 1.62 | 1.09 | 1.2 | 0.97 |
Other Current Assets | - | - | - | -0 | - | - |
Total Current Assets | 7.48 | 9.14 | 7.77 | 7.2 | 11.82 | 13.44 |
Property, Plant & Equipment | 0.17 | 0.12 | 0 | 0.01 | 0.04 | 0.07 |
Other Intangible Assets | 3.3 | 1.93 | 2.09 | 2.2 | 2.09 | 1.76 |
Long-Term Deferred Charges | - | 1.86 | 3.35 | 5.25 | 7.34 | 10.39 |
Other Long-Term Assets | 0.16 | 0.16 | 0.17 | 0.21 | 0.42 | 0.15 |
Total Assets | 11.11 | 13.2 | 13.38 | 14.87 | 21.7 | 25.81 |
Accounts Payable | - | 1.86 | 1.42 | 2.39 | 1.82 | 1.01 |
Accrued Expenses | - | 1.15 | 0.8 | 1.07 | 0.82 | 0.52 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.05 |
Other Current Liabilities | 9.47 | 7.01 | 5.18 | 0.38 | 5.07 | 0.31 |
Total Current Liabilities | 9.47 | 10.01 | 7.4 | 3.84 | 7.71 | 1.89 |
Total Liabilities | 9.47 | 10.01 | 7.4 | 3.84 | 7.71 | 1.89 |
Common Stock | 1.64 | 12.73 | 11.67 | 8.97 | 6.01 | 4.82 |
Additional Paid-In Capital | - | 120.93 | 116.89 | 111.05 | 95.63 | 84.27 |
Retained Earnings | - | -8.06 | -13.72 | -21.09 | -22.75 | -17.74 |
Comprehensive Income & Other | - | -122.41 | -108.87 | -87.9 | -64.9 | -47.43 |
Shareholders' Equity | 1.64 | 3.19 | 5.98 | 11.03 | 13.99 | 23.92 |
Total Liabilities & Equity | 11.11 | 13.2 | 13.38 | 14.87 | 21.7 | 25.81 |
Total Debt | - | - | - | - | - | 0.05 |
Net Cash (Debt) | 1.46 | 3.67 | 0.95 | 0.92 | 5.85 | 8.63 |
Net Cash Growth | 43.07% | 286.51% | 2.82% | -84.23% | -32.18% | - |
Net Cash Per Share | 0.06 | 0.15 | 0.05 | 0.07 | 0.59 | 1.00 |
Filing Date Shares Outstanding | 25.45 | 25.45 | 23.34 | 17.94 | 12.01 | 9.63 |
Total Common Shares Outstanding | 25.45 | 25.45 | 23.34 | 17.94 | 12.01 | 9.63 |
Working Capital | -1.99 | -0.88 | 0.37 | 3.36 | 4.11 | 11.54 |
Book Value Per Share | 0.06 | 0.13 | 0.26 | 0.61 | 1.16 | 2.48 |
Tangible Book Value | -1.66 | 1.25 | 3.89 | 8.83 | 11.9 | 22.16 |
Tangible Book Value Per Share | -0.07 | 0.05 | 0.17 | 0.49 | 0.99 | 2.30 |
Machinery | - | 0.45 | 0.32 | 0.32 | 0.32 | 0.32 |